CCOLA:BISTCoca-Cola Icecek A.S. Analysis
Data as of 2026-06-01 - not real-time
TRY 80.55
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Coca‑Cola Içecek is trading at 80.55 TRY, comfortably above its 30‑day support of 74.15 TRY but still below the 20‑day SMA of 82.06, indicating a near‑term price cushion with room to test the next resistance near 89.20. The stock shows a bullish trend direction yet the MACD has turned bearish and volume is decreasing, suggesting a short‑term pause. Fundamentally, the company delivers solid growth with 10.7% revenue expansion, a 9.2% profit margin and a healthy ROE of 22%, while operating cash flow exceeds 35 bn TRY, supporting a low 17% payout ratio and a 1.79% dividend yield. Valuation metrics point to upside: the DCF fair value of 87.54 TRY and analyst median target of 97 TRY imply roughly 22% upside, while the forward PE of 8.6 is well below the current 12.8 trailing PE. The balance sheet is mixed – cash of 25.3 bn TRY offsets a sizable debt of 51.7 bn TRY, yielding a debt‑to‑equity of 54%, but the low beta of 0.12 and defensive consumer‑staples sector provide stability. Market sentiment is extremely bullish (Fear‑Greed Index 92.66) and analysts collectively rate the stock as a strong buy, reinforcing the upside case. Overall, the company’s brand strength, dividend sustainability, and defensive positioning make it an attractive buy for investors with medium to long horizons, while short‑term traders may wait for a clearer technical breakout.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price near support but below short‑term SMA
- Bearish MACD histogram indicating potential pullback
- Decreasing volume suggesting lower short‑term momentum
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to DCF and analyst targets
- Strong earnings growth and cash flow generation
- Low payout ratio and sustainable dividend yield
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Defensive consumer‑staples sector with brand resilience
- Low beta and stable cash generation supporting dividend
- Long‑term upside potential of ~22% versus current price
Key Metrics & Analysis
Financial Health
Revenue Growth10.70%
Profit Margin9.18%
P/E Ratio12.8
ROE21.99%
ROA9.22%
Debt/Equity54.13
P/B Ratio2.7
Op. Cash FlowTRY35.5B
Free Cash FlowTRY13.1B
Technical Analysis
TrendBullish
RSI52.8
SupportTRY 74.15
ResistanceTRY 89.20
MA 20TRY 82.06
MA 50TRY 76.47
MA 200TRY 62.94
MACDBearish
VolumeDecreasing
Fear & Greed Index92.66
Valuation
Fair ValueTRY 87.54
Target PriceTRY 98.42
Upside/Downside22.19%
GradeUndervalued
TypeBlend
Dividend Yield1.79%
Risk Assessment
Beta0.12
Volatility31.53%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.